Cancer-related fatigue—mechanisms, risk factors, and treatments
JE Bower - Nature reviews Clinical oncology, 2014 - nature.com
Fatigue is one of the most common adverse effects of cancer that might persist for years after
treatment completion in otherwise healthy survivors. Cancer-related fatigue causes …
treatment completion in otherwise healthy survivors. Cancer-related fatigue causes …
ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs–threshold doses for tissue reactions in a …
FA Stewart, AV Akleyev, M Hauer-Jensen, JH Hendry… - Annals of the ICRP, 2012 - Elsevier
This report provides a review of early and late effects of radiation in normal tissues and
organs with respect to radiation protection. It was instigated following a recommendation in …
organs with respect to radiation protection. It was instigated following a recommendation in …
Radiation-induced lung toxicity–cellular and molecular mechanisms of pathogenesis, management, and literature review
L Käsmann, A Dietrich, CA Staab-Weijnitz… - Radiation …, 2020 - Springer
Lung, breast, and esophageal cancer represent three common malignancies with high
incidence and mortality worldwide. The management of these tumors critically relies on …
incidence and mortality worldwide. The management of these tumors critically relies on …
Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications
Fatigue is one of the most common and distressing side effects of cancer and its treatment,
and may persist for years after treatment completion in otherwise healthy survivors. Guided …
and may persist for years after treatment completion in otherwise healthy survivors. Guided …
Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer
Purpose: Biomarkers of radiation-induced behavioral symptoms, such as fatigue, have not
been identified. Studies linking inflammatory processes to fatigue in cancer survivors led us …
been identified. Studies linking inflammatory processes to fatigue in cancer survivors led us …
Radiation pulmonary toxicity: from mechanisms to management
PR Graves, F Siddiqui, MS Anscher… - Seminars in radiation …, 2010 - Elsevier
The goal of radiation therapy is to reduce or eliminate tumor burden while sparing normal
tissues from long-term injury. Thoracic radiation presents a unique challenge because of the …
tissues from long-term injury. Thoracic radiation presents a unique challenge because of the …
Cytokines and radiation-induced pulmonary injuries
A Lierova, M Jelicova, M Nemcova… - Journal of radiation …, 2018 - academic.oup.com
Radiation therapy is one of the most common treatment strategies for thorax malignancies.
One of the considerable limitations of this therapy is its toxicity to normal tissue. The lung is …
One of the considerable limitations of this therapy is its toxicity to normal tissue. The lung is …
Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL
PM Barr, GB Saylors, SE Spurgeon… - Blood, The Journal …, 2016 - ashpublications.org
Although agents targeting B-cell receptor signaling have provided practice-changing results
in relapsed chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL), they …
in relapsed chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL), they …
p53 and NF-κB coregulate proinflammatory gene responses in human macrophages
JM Lowe, D Menendez, PR Bushel, M Shatz, EL Kirk… - Cancer research, 2014 - AACR
Macrophages are sentinel immune cells that survey the tissue microenvironment, releasing
cytokines in response to both exogenous insults and endogenous events such as …
cytokines in response to both exogenous insults and endogenous events such as …
Development and validation of a radiomics nomogram using computed tomography for differentiating immune checkpoint inhibitor-related pneumonitis from radiation …
Q Qiu, L Xing, Y Wang, A Feng, Q Wen - Frontiers in Immunology, 2022 - frontiersin.org
Background The combination of immunotherapy and chemoradiotherapy has become the
standard therapeutic strategy for patients with unresected locally advance-stage non-small …
standard therapeutic strategy for patients with unresected locally advance-stage non-small …